Search research articles
Contact Us
Filters
Showing results (121-130 of 491) with videos related to
Page
of 50
Sort By:
JHEP Reports : Innovation in Hepatology
|
February 4, 2026
Reply to: "Predicting the need for early TIPS in patients with cirrhosis and ascites: More art than science"
Lorenz Balcar, Marta Tonon, Joan Valls, et al.
Plos One
|
April 12, 2016
Impact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, Austria
Sandra Herout, Mattias Mandorfer, Florian Breitenecker, et al.
Hepatology Communications
|
October 27, 2023
Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib study
Eric J Lawitz, Thomas Reiberger, Jörn M Schattenberg, et al.
Journal of Hepatology
|
June 7, 2024
EASL position paper on clinical follow-up after HCV cure
Thomas Reiberger, Sabela Lens, Giuseppe Cabibbo, et al.
Wiener Klinische Wochenschrift
|
June 16, 2012
Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience
Thomas Reiberger, Arnulf Ferlitsch, Berit Anna Payer, et al.
Hepatology International
|
April 6, 2023
Endoscopic band ligation is safe despite low platelet count and high INR
Nikolaus Pfisterer, Michael Schwarz, Mathias Jachs, et al.
Plos One
|
August 24, 2023
Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes
Michael Schwarz, Caroline Schwarz, Lukas Burghart, et al.
Antiviral Therapy
|
February 7, 2009
IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection
Thomas Reiberger, Judith H Aberle, Michael Kundi, et al.
Plos One
|
April 7, 2023
Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients
Lorenz Balcar, David Bauer, Katharina Pomej, et al.
Scientific Reports
|
December 8, 2019
Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction
Daniel Dalos, Christina Binder, Franz Duca, et al.
Page
of 50
Search research articles
Search
Showing results (121-130 of 491) with videos related to
Sort By:
Page
of 50
JHEP Reports : Innovation in Hepatology
|
February 4, 2026
Reply to: "Predicting the need for early TIPS in patients with cirrhosis and ascites: More art than science"
Lorenz Balcar, Marta Tonon, Joan Valls, et al.
Plos One
|
April 12, 2016
Impact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, Austria
Sandra Herout, Mattias Mandorfer, Florian Breitenecker, et al.
Hepatology Communications
|
October 27, 2023
Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib study
Eric J Lawitz, Thomas Reiberger, Jörn M Schattenberg, et al.
Journal of Hepatology
|
June 7, 2024
EASL position paper on clinical follow-up after HCV cure
Thomas Reiberger, Sabela Lens, Giuseppe Cabibbo, et al.
Wiener Klinische Wochenschrift
|
June 16, 2012
Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience
Thomas Reiberger, Arnulf Ferlitsch, Berit Anna Payer, et al.
Hepatology International
|
April 6, 2023
Endoscopic band ligation is safe despite low platelet count and high INR
Nikolaus Pfisterer, Michael Schwarz, Mathias Jachs, et al.
Plos One
|
August 24, 2023
Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes
Michael Schwarz, Caroline Schwarz, Lukas Burghart, et al.
Antiviral Therapy
|
February 7, 2009
IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection
Thomas Reiberger, Judith H Aberle, Michael Kundi, et al.
Plos One
|
April 7, 2023
Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients
Lorenz Balcar, David Bauer, Katharina Pomej, et al.
Scientific Reports
|
December 8, 2019
Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction
Daniel Dalos, Christina Binder, Franz Duca, et al.
Page
of 50